Pathological neovascularisation, which is a critical component of diseases such as age-related macular degeneration（AMD）, diabetic retinopathy（DR） and retinopathy of prematurity（ROP）, is a frequent cause of comp...Pathological neovascularisation, which is a critical component of diseases such as age-related macular degeneration（AMD）, diabetic retinopathy（DR） and retinopathy of prematurity（ROP）, is a frequent cause of compromised vision or blindness. Researchers continuously investigate the role of the complement system in the pathogenesis of retinopathy. Studies have confirmed the role of factors H and I in the development of AMD, and factors H and B in the development of DR. Other components, such as C2, C3, and C5, have also been considered. However, findings on the involvement of the complement system in the pathogenesis of ROP are still inconclusive. This paper presents a review of the current literature data, pointing to the novel results and achievements from research into the role of complement components in the development of retinopathy. There is still a need to continue research in new directions, and to gather more detailed information about this problem which will be useful in the treatment of these diseases.展开更多
文摘Pathological neovascularisation, which is a critical component of diseases such as age-related macular degeneration（AMD）, diabetic retinopathy（DR） and retinopathy of prematurity（ROP）, is a frequent cause of compromised vision or blindness. Researchers continuously investigate the role of the complement system in the pathogenesis of retinopathy. Studies have confirmed the role of factors H and I in the development of AMD, and factors H and B in the development of DR. Other components, such as C2, C3, and C5, have also been considered. However, findings on the involvement of the complement system in the pathogenesis of ROP are still inconclusive. This paper presents a review of the current literature data, pointing to the novel results and achievements from research into the role of complement components in the development of retinopathy. There is still a need to continue research in new directions, and to gather more detailed information about this problem which will be useful in the treatment of these diseases.
